BioSpace News Archive

AbbVie (NYSE: ABBV) and Harvard University today announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel therapies against emergent viral infections, with a focus on those caused by coronaviruses and by vi

Most adults with systemic lupus erythematosus are not at increased risk of hospitalization from COVID-19 due to medications used to dampen their altered immune system, the cause of their disease.

TAGNOS, a developer of workflow orchestration software for hospital operations, today announced its Proximity Monitoring Module designed to support the Zebra MotionWorks ® devices line.

- Revance is positioned to introduce its innovative aesthetics portfolio, starting with the launch of the RHA® Collection, the first and only FDA-approved dermal fillers for correction of dynamic facial wrinkles and folds - - Clinical study results support the efficacy and safety of these globally established and innovative hyaluronic acid (HA) gels that represent the latest HA filler technology - - 100+ field force in place and trained for laun

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that the European Patent Office has notified the Company of its intent to grant a patent for the invention titled “An A3 Adenosine Receptor For Use In Treating Ectopic Fat Acculturation”

SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced that EVERSANA has appointed Christopher Quesenberry as Chief Commercial Officer for Gimoti™. In June 2020, Gimoti was approved by the Food and Drug Administration for the relief of symptoms in

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it will be presenting at the 12th Annual LD 500 Conference on Wednesday, September 2, 2020, at 11:40 AM ET. Kenneth L. Londoner, Chairman and CEO of BioSig Technolo

- Kintara Therapeutics, Inc. (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has closed its previously announced private placement with investors providing for the sale and issuance of 2,185 shares of its Series C Convertible Preferred Stock (the “Preferred Stock”) at a purchase price of $1,000 per share priced at-the-m

The American Society of Pharmacovigilance (ASP) today announced that the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Initiative has developed a collaborative community with participation by the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH). ASP is convening the STRIPE commun

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will participate in the following investor conferences during the month of September 2020: the LD 500 Virtual Investor Conference on September 1-4, 2020, and the H.C. Wainwright 22 nd Annual Global Investment Conference on September 14-16, 2020. Calyxt Chief Executive Officer Jim Blome and